These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 27512733)
1. Resolution of osteosclerosis after alloHCT in systemic mastocytosis. Ustun C; Courville EL Blood; 2016 Apr; 127(14):1836. PubMed ID: 27512733 [No Abstract] [Full Text] [Related]
2. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val. Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. Sotlar K Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Yavuz AS; Lipsky PE; Yavuz S; Metcalfe DD; Akin C Blood; 2002 Jul; 100(2):661-5. PubMed ID: 12091362 [TBL] [Abstract][Full Text] [Related]
5. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case? Akin C; Scott LM; Metcalfe DD Leuk Res; 2001 Jul; 25(7):635-8. PubMed ID: 11377688 [TBL] [Abstract][Full Text] [Related]
7. Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia. Sotlar K; Marafioti T; Griesser H; Theil J; Aepinus C; Jaussi R; Stein H; Valent P; Horny HP Mol Pathol; 2000 Aug; 53(4):188-93. PubMed ID: 11040941 [TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: advances in diagnosis and treatment. Hungness SI; Akin C Curr Allergy Asthma Rep; 2007 Jul; 7(4):248-54. PubMed ID: 17547845 [TBL] [Abstract][Full Text] [Related]
9. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840 [TBL] [Abstract][Full Text] [Related]
10. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. Zappulla JP; Dubreuil P; Desbois S; Létard S; Hamouda NB; Daëron M; Delsol G; Arock M; Liblau RS J Exp Med; 2005 Dec; 202(12):1635-41. PubMed ID: 16352739 [TBL] [Abstract][Full Text] [Related]
11. Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series. Tanasi I; Bonifacio M; Pizzolato M; Irene Grifoni F; Sciumè M; Elena C; Benvenuti P; Mannelli F; Parente R; Schena D; Scaffidi L; Bonadonna P; Papayannidis C; Rondoni M; Criscuolo M; Vannucchi AM; Triggiani M; Martinelli G; Krampera M; Zanotti R Br J Haematol; 2021 May; 193(4):845-848. PubMed ID: 33754335 [No Abstract] [Full Text] [Related]
17. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925 [TBL] [Abstract][Full Text] [Related]
18. Mastocytosis cells bearing a c-kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis. Dror Y; Leaker M; Caruana G; Bernstein A; Freedman MH Br J Haematol; 2000 Mar; 108(4):729-36. PubMed ID: 10792276 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Arock M; Valent P Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038 [TBL] [Abstract][Full Text] [Related]